Acehytisine demonstrates atrial-selective sodium channel blockade, providing mechanistic evidence for its efficacy in terminating and preventing atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Effects on Na channels in rabbit myocytes extend mechanistic data; clinical translation for AF remains unproven.
Acehytisine, a multi-ion channel blocker, can markedly inhibit I Na , I Ca , I Kur , I f at various concentrations and effectively terminate and prevent atrial fibrillation (AF) in patients and animal models, but the molecular mechanism underlying its blockage remains elusive. In this study, we investigated the effects of acehytisine on action potentials and sodium channels of atrial and ventricular myocytes isolated from rabbit, using whole-cell recording system. We found that acehytisine exerted stronger blocking effects on sodium channels in atria than in ventricles, especially at depolarization (IC 50 : 48.48 ± 7.75 μmol/L in atria vs. 560.17 ± 63.98 μmol/L in ventricles). It also significantly shifted steady state inactivation curves toward negative potentials in atrial myocytes, without affecting the recovery kinetics from inactivation of sodium channels in the same cells. In addition, acehytisine inhibited I Na in a use-dependent manner and regulated slow inactivation kinetics by different gating configurations. These findings indicate that acehytisine selectively blocks atrial sodium channels and possesses affinity to sodium channel in certain states, which provides additional evidence for the anti-AF of acehytisine.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: